Forepont Capital Partners is a New York-based venture capital firm focused on biotech, medtech, and digital health. The firm typically invests at seed and Series A stage in companies developing clinical devices, diagnostics, and therapeutics across the United States and Europe.

It has taken notable positions in the brain-computer interface space through investments in Precision Neuroscience and Synchron. Those investments indicate a clear belief in the clinical and commercial potential of neural interface technologies for restoring function and treating neurological conditions.

Forepont maintains a transatlantic investment strategy spanning the United States and Europe. Its combined biotech and medtech focus makes it particularly relevant for neurotechnology companies operating close to the clinical and regulatory path rather than consumer neurotech.